Setiptiline
Drug profile
Also known as: Org-8282, setiptiline maleate, teciptilline, tecipul
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Setiptiline is a drug catalogued in DrugCentral. Recorded indications include Depressive disorder.
- Indications: Depressive disorder.
- Molecular formula: C19H19N; molecular weight 261.37 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Depressive disorder
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Setiptiline is on its molecule page.
| Molecular formula | C19H19N |
|---|---|
| Molecular weight | 261.37 g/mol |
| CAS number | — |
| InChIKey | GVPIXRLYKVFFMK-UHFFFAOYSA-N |
| PubChem CID | 5205 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Setiptiline used for?
DrugCentral lists the following indications for Setiptiline: Depressive disorder.
What is the chemical formula of Setiptiline?
Setiptiline has the molecular formula C19H19N and a molecular weight of 261.37 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2438 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2104895 — compound record and bioactivity
- PubChem CID 5205 — chemical identifiers
- DrugBank DB09304 — drug record
- FDA UNII 7L38105Z6E — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.